WS Investment Management Co.

WS Investment Management Co.

WS Investment Management Co.

Date Founded



650 Page Mill Road, Palo Alto, California, 94304

Type of Company



Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

WS Investment Management Co. has significant expertise in the technology, life sciences, and clean technology sectors.

Contact Data
Trying to get in touch with decision makers at WS Investment Management Co.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees
Paths to WS Investment Management Co.
Potential Connections via
Relationship Science
WS Investment Management Co.
Recent Transactions
Details Hidden

Kemet Corp. purchases Novasentis, Inc. from Samsung Venture Investment Corp., Chengwei Capital Co., Ltd., WS Investment Management Co.

Details Hidden

The Carlyle Group LP (Corporate Private Equity) purchases HireVue, Inc. from Granite Ventures LLC, Sequoia Capital, TCMI, Inc., Patricia Industries, Inc., Peterson Ventures LLC, Rose Park Advisors LLC, WS Investment Management Co., Delta-V Capital LLC

Details Hidden

purchases Wayin from U.S. Venture Partners, WS Investment Management Co., Hasso Plattner Ventures Management GmbH

Details Hidden

BioSkryb, Inc. provides cellular heterogeneity solutions. It offers Bioskryb's SkrybAmp technology that enables even coverage of the entire genome during DNA amplification and allows for unprecedented accuracy and uniformity in DNA sequence coverage and base calling. The company was founded by Jay West and Charles Gawad and is headquartered in Durham, NC.

Details Hidden

Activ Surgical, Inc. provides healthcare services. The firm focuses on improving surgical efficiency, accuracy, patient outcomes and accessibility for both endoscopic and robotically-assisted procedures. The company was founded by Peter C. W. Kim in 2014 and is headquartered in Washington, DC.

Details Hidden

Metabiotech Corp. operates a platform technology for reading and fixing DNA. Its synthetic biology solutions accelerate the design-build-test cycle for biotechnology and bioengineering and genomics pipeline that discovers clinically actionable genetic information for human diseases. The company was founded by Tuval Ben-Yehezkel and is headquartered in San Jose, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by WS Investment Management Co.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of WS Investment Management Co.'s profile does not indicate a business or promotional relationship of any kind between RelSci and WS Investment Management Co..